Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Withdrawn Phase 1 / 2 Trials for Docetaxel (DB01248)

Also known as: Stage IIIB Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090338 (Stage IIIB Non-Small Cell Lung Cancer AJCC v7)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03370159CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerTreatment